Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 279-285

  Williamson, Laura M ^a   Lees Miller, Susan P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; CYCLIN A; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) B; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HISTONE H2AX; RAD51 PROTEIN;

ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 79952283912     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq255     Document Type: Article

References (40)

1. Liehr, J.G. (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev., 21, 40-54.
2. Rajapakse, N. et al. (2005) Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites. Environ. Mol. Mutagen., 45, 397-404.
3. Rossi, D. et al. (2007) In vitro short-term test evaluation of catecholestrogens genotoxicity. J. Steroid Biochem. Mol. Biol., 105, 98-105.
4. Roy, D. et al. (1999) Estrogen, DNA damage and mutations. Mutat. Res., 424, 107-115.
5. Jackson, S.P. et al. (2009) The DNA-damage response in human biology and disease. Nature, 461, 1071-1078.
6. Ju, B.G. et al. (2006) A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science, 312, 1798-1802.
7. Nitiss, J.L. (2009) DNA topoisomerase II and its growing repertoire of biological functions. Nat. Rev. Cancer, 9, 327-337.
8. Pommier, Y. et al. (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol., 17, 421-433.
9. Pui, C.H. et al. (2000) Topoisomerase II inhibitor-related acute myeloid leukaemia. Br. J. Haematol., 109, 13-23.
10. McClendon, A.K. et al. (2007) DNA topoisomerase II, genotoxicity, and cancer. Mutat. Res., 623, 83-97.
11. Lobrich, M. et al. (2010) gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle, 9, 662-669.
12. Douglas, P. et al. (2010) Protein phosphatase 6 interacts with the DNA-dependent protein kinase catalytic subunit and dephosphorylates gamma-H2AX. Mol. Cell Biol., 30, 1368-1381.
13. Berkovich, E. et al. (2008) Assessment of protein dynamics and DNA repair following generation of DNA double-strand breaks at defined genomic sites. Nat. Protoc., 3, 915-922.
14. Stiff, T. et al. (2004) ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res., 64, 2390-2396.
15. Mukherjee, B. et al. (2006) DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair (Amst.), 5, 575-590.
16. Hickson, I. et al. (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res., 64, 9152-9159.
17. Zhao, Y. et al. (2006) Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res., 66, 5354-5362.
18. Ward, I.M. et al. (2001) Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem., 276, 47759-47762.
19. Chen, Z.H. et al. (2005) 4-Hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells: possible protection by NF-kappaB and ERK/MAPK. Toxicol. Appl. Pharmacol., 208, 46-56.
20. Saeed, M. et al. (2007) Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int. J. Cancer, 120, 1821-1824.
21. Wakeling, A.E. et al. (1992) ICI 182, 780, a new antioestrogen with clinical potential. J. Steroid Biochem. Mol. Biol., 43, 173-177.
22. Wong, R.H. et al. (2009) A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell, 136, 1056-1072.
23. Drake, F.H. et al. (1989) In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Cancer Res., 49, 2578-2583.
24. Mensah-Osman, E.J. et al. (2002) 2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]-propionic acid (XK469) inhibition of topoisomerase IIbeta is not sufficient for therapeutic response in human Waldenstrom's macroglobulinemia xenograft model. Mol. Cancer Ther., 1, 1315-1320.
25. MacPhail, S.H. et al. (2003) Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G1-phase cells. Radiat. Res., 159, 759-767.
26. Tashiro, S. et al. (2000) Rad51 accumulation at sites of DNA damage and in postreplicative chromatin. J. Cell Biol., 150, 283-291.
27. Beucher, A. et al. (2009) ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2. EMBO J., 28, 3413-3427.
28. Moynahan, M.E. et al. (2010) Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat. Rev. Mol. Cell Biol., 11, 196-207.
29. Lin, C. et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell, 139, 1069-1083.
30. Haffner, M.C. et al. (2010) Androgen-induced TOP2B-mediated doublestrand breaks and prostate cancer gene rearrangements. Nat. Genet., 42, 668-675.
31. Medunjanin, S. et al. (2010) Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha. Mol. Biol. Cell, 21, 1620-1628.
32. Pedram, A. et al. (2009) Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell, 20, 3374-3389.
33. Cimprich, K.A. et al. (2008) ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol., 9, 616-627.
34. Chanoux, R.A. et al. (2009) ATR and H2AX cooperate in maintaining genome stability under replication stress. J. Biol. Chem., 284, 5994-6003.
35. Welboren, W.J. et al. (2009) ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J., 28, 1418-1428.
36. Iacovoni, J.S. et al. (2010) High-resolution profiling of gammaH2AX around DNA double strand breaks in the mammalian genome. EMBO J., 29, 1446-1457.
37. Renwick, A. et al. (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet., 38, 873-875.
38. Hsu, H.M. et al. (2007) Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol. Biomarkers Prev., 16, 2024-2032.
39. O'Donovan, P. et al. (2010) BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double strand break repair. Carcinogenesis, 31, 961-967.
40. Ding, S.L. et al. (2009) Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis, 30, 43-49.